HLA-A*02 + MAGEA4 expression	Solid Tumor	HLA-A*02 + MAGEA4 expression	Solid Tumor	ADP-A2M4CD8 Sensitive: C3 – Early Trials ADP-A2M4CD8 Sensitive : C3	ADP-A2M4CD8 Sensitive: C3 – Early Trials ADP-A2M4CD8 Sensitive : C3
HLA-A*02 + MAGEA4 expression	Soft Tissue Sarcoma	HLA-A*02 + MAGEA4 expression	Soft Tissue Sarcoma	afamitresgene autoleucel Sensitive: C3 – Early Trials afamitresgene autoleucel Sensitive : C3	afamitresgene autoleucel Sensitive: C3 – Early Trials afamitresgene autoleucel Sensitive : C3
HLA-A*02 + MAGEA4 expression	Ovarian Cancer	HLA-A*02 + MAGEA4 expression	Ovarian Cancer	IMC-C103C Sensitive: C3 – Early Trials IMC-C103C Sensitive : C3	IMC-C103C Sensitive: C3 – Early Trials IMC-C103C Sensitive : C3

HLA-A*02 + MAGEA4 expression

Associations